“Paul Walker”

As a Name:  Registrant, Group Member and/or Signatory

        

Latest Filing:  5/13/24  as  ↓Group Member

As:  Registrant

        

As:  Group Member  (Co-Filer Non-Registrant:  Partner, Affiliate, etc.)

“Paul Walker” has been a Group Member with  7  Filers:

        

As Of	Filer			Filings       #        Latest		Issuer     (Primary)
5/13/24		MD	New Enterprise Associates 17, L.P.	7	SC 13D/A	MA	Monte Rosa Therapeutics, Inc.
5/13/24		MD	New Enterprise Associates 16, L.P.	22	SC 13D/A	MA	Black Diamond Therapeutics, Inc.
4/10/24		MD	New Enterprise Associates 15, L.P.	7	SC 13D/A	FL	NeueHealth, Inc.
3/18/24		MD	Growth Equity Opportunities V, LLC	13	SC 13D/A	CA	Regulus Therapeutics Inc.
7/28/23		MD	Growth Equity Opportunities 18 VGE, LLC	6	SC 13D	CA	Gossamer Bio, Inc.
7/26/23		MD	Growth Equity Opportunities 17, LLC	10	SC 13D/A	TX	Savara Inc.
9/7/22		MD	Growth Equity Opportunities Fund IV, LLC	2	SC 13D/A		Verona Pharma plc

“Paul Walker” has/had a Group Member interest in  24  Issuers:

As Of	Issuer			Filings       #        Latest		With Filer     (Primary)
5/13/24		MA	Monte Rosa Therapeutics, Inc.	2	SC 13D/A	MD	New Enterprise Associates 17, L.P.
5/13/24		MA	Black Diamond Therapeutics, Inc.	2	SC 13D/A	MD	New Enterprise Associates 16, L.P.
5/3/24			Inventiva S.A.	2	SC 13D/A	MD	New Enterprise Associates 17, L.P.
4/24/24		MA	Korro Bio, Inc.	2	SC 13D/A	MD	New Enterprise Associates 17, L.P.
4/10/24		FL	NeueHealth, Inc.	8	SC 13D/A	MD	New Enterprise Associates 15, L.P.
3/18/24		CA	Regulus Therapeutics Inc.	4	SC 13D/A	MD	Growth Equity Opportunities V, LLC
12/29/23		CA	Mirum Pharmaceuticals, Inc.	3	SC 13D/A	MD	New Enterprise Associates 16, L.P.
7/28/23		CA	Gossamer Bio, Inc.	1	SC 13D	MD	Growth Equity Opportunities 18 VGE, LLC
7/26/23		TX	Savara Inc.	2	SC 13D/A	MD	Growth Equity Opportunities 17, LLC
5/26/23		MA	X4 Pharmaceuticals, Inc.	3	SC 13D/A	MD	Growth Equity Opportunities 18 VGE, LLC
5/2/23		NC	Satsuma Pharmaceuticals, Inc.	3	SC 13D/A	MD	Growth Equity Opportunities 17, LLC
3/9/23		CA	MEI Pharma, Inc.	2	SC 13D/A	MD	Growth Equity Opportunities V, LLC
2/3/23		CA	Geron Corp.	2	SC 13D/A	MD	Growth Equity Opportunities 17, LLC
10/28/22		MA	Akouos, Inc.	2	SC 13D/A	MD	New Enterprise Associates 16, L.P.
10/11/22		CA	Allakos Inc.	2	SC 13D	MD	New Enterprise Associates 16, L.P.
9/12/22		MN	Celcuity Inc.	2	SC 13D/A	MD	Growth Equity Opportunities 18 VGE, LLC
9/7/22			Verona Pharma plc	2	SC 13D/A	MD	Growth Equity Opportunities Fund IV, LLC
8/12/22		CA	Vistagen Therapeutics, Inc.	3	SC 13D/A	MD	Growth Equity Opportunities 17, LLC
7/22/22		WA	Cti Biopharma Corp.	3	SC 13D/A	MD	Growth Equity Opportunities V, LLC
5/27/22		MA	Genocea Biosciences, Inc.	5	SC 13D/A	MD	New Enterprise Associates 16, L.P.
			More...  Please Sign In to list all 24 of them.

“Paul Walker” has been a Group Member with  32  other Group Members:

As Of	Group Member			Filings       #        Latest		With Filer     (Primary)		Issuer     (Primary)
5/13/24		CA	Ali Behbahani	67	SC 13D/A	MD	New Enterprise Associates 17, L.P.	MA	Monte Rosa Therapeutics, Inc.
		MD	Anthony A. Florence, Jr.	67
		CA	Carmen Chang	67
		MD	Edward T. Mathers	33
		CA	Forest Baskett	60
		•	Mohamad H. Makhzoumi	66
		MD	Nea 17 GP, LLC	26
		MD	Nea Partners 17, L.P.	26
		CA	Rick Yang	33
		MD	Scott D. Sandell	67
5/13/24		MD	Nea 16 GP, LLC	43	SC 13D/A	MD	New Enterprise Associates 16, L.P.	MA	Black Diamond Therapeutics, Inc.
		MD	NEA Partners 16, L.P.	43
4/10/24		MD	Nea 15 GP, LLC	10	SC 13D/A	MD	New Enterprise Associates 15, L.P.	FL	NeueHealth, Inc.
		MD	Nea 15 Opportunity Fund, L.P.	8
		MD	NEA 18 Venture Growth Equity, L.P.	14
		MD	Nea 18 Vge GP, LLC	14
		•	Nea BH SPV GP, LLC	8
		MD	Nea BH SPV II, L.P.	8
		MD	Nea BH SPV, L.P.	8
		MD	NEA Partners 15, L.P.	10
			More...  Please Sign In to list all 32 of them.

As:  Signatory  (Director, Officer, Attorney, Accountant, Banker, Agent, etc.)

“Paul Walker” has been a Signatory for/with  6  Filers:

        

As Of	Filer			Filings       #        Latest		Issuer     (Primary)
3/14/24		CA	Allakos Inc.	11	10-K	—
6/7/23			Relx plc	3	S-8	—
4/29/22		DE	RELX Capital Inc.	1	F-3ASR	—
11/2/21		GA	OneWater Marine Inc.	2	8-K	—
3/18/21			Trillium Therapeutics Inc.	3	S-3ASR	—
3/2/21			Valaris Ltd.	1	10-K	—